Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 11Colonic Neoplasms 7Breast Neoplasms 7Lung Neoplasms 6Brain Neoplasms 4Urinary Bladder Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Respiratory Aspiration 2Rectal Neoplasms 2Prostatic Neoplasms 2Postoperative Complications 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neoplastic Cells, Circulating 2Neoplasm Metastasis 2Melanoma 2Uterine Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Recurrence 1Quality of Recovery 1Postoperative Cognitive Complications 1Pain, Postoperative 1Neurofibromatoses 1Myofibroma 1Liver Neoplasms 1Liver Functions Tests 1Intraoral Tumor 1Inflammation 1

Interventions

Gemcitabine 82Cisplatin 52Oxaliplatin 36lenvatinib 24durvalumab 22Capecitabine 22Fluorouracil 20Leucovorin 15tislelizumab 11pembrolizumab 10apatinib 10Radiotherapy 10Albumin-Bound Paclitaxel 10Radiofrequency Ablation 9Magnetic Resonance Spectroscopy 9Irinotecan 9Floxuridine 9Liver Transplantation 8Drug Therapy 8Cholangiopancreatography, Endoscopic Retrograde 8130-nm albumin-bound paclitaxel 8Taxes 7Platinum 7Photochemotherapy 7Panitumumab 7Biopsy 71,2-diaminocyclohexaneplatinum II citrate 7tremelimumab 6pemigatinib 6camrelizumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cholangiocarcinoma × Sevoflurane × Clear all
NCT02174575 2023-05-03

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Tokyo Medical and Dental University

Phase 4 Withdrawn
Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡